Pulse Biosciences (PLSE) | Stock Overview & Key Data
Pulse Biosciences Performance Comparison
Stock Range
Today's Range
52 Week Range
All-Time High: $45.82 on February 8, 2021
Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights
Key Statistics
Join Our United States Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Financial Highlights
Quarter Income Flow
Dec 31, 2025
Annual Income Flow
2025
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Pulse Biosciences
PLSE
|
1.65B Small-cap | 4.35% | 5.58% | 18.74% | 83.44% | 93.58% | 54.53% | 288.68% | 40.54% | 457.67% | 490.07% | 490.07% |
|
Intuitive Surgical
ISRG
|
170.06B Large-cap | -0.49% | -1.09% | -13.84% | -25.55% | -25.88% | -19.74% | 24.81% | 40.32% | 476.52% | 974.11% | 3,431.44% |
| 56.10B Large-cap | -2.98% | 1.43% | -9.20% | -7.49% | -5.04% | 8.01% | -28.08% | -20.73% | 15.00% | 123.99% | 212.28% | |
|
AtriCure
ATRC
|
1.43B Small-cap | 3.94% | -0.50% | -8.08% | -31.82% | -28.75% | -8.95% | -40.16% | -61.38% | 94.66% | 127.41% | 234.77% |
|
Staar Surgical
STAA
|
1.23B Small-cap | -5.31% | -11.54% | 56.91% | 20.42% | 20.21% | 66.10% | -46.07% | -80.50% | 419.60% | 454.10% | 273.29% |
|
Anbio Biotechnology
NNNN
|
1.20B Small-cap | -2.38% | -37.60% | -22.96% | -40.81% | -42.98% | 80.02% | 170.19% | 170.19% | 170.19% | 170.19% | 170.19% |
Ownership & Short Interest
Calculate Your Pulse Biosciences Investment Returns
Long-Term Investment Performance Analysis
Pulse Biosciences stock price in Jul 2016 was $4.50, A $1,000.00 lump sum investment in Pulse Biosciences made 9 years ago would be worth approximately $5,760.00 today, representing a exceptional return of 476.00%. This translates to an annualized return (CAGR) of 19.33%.
9 Years 10 Months Investment Scenario (Jul 2016 - Jun 2026)
Investment Breakdown
Value Comparison
Disclaimer: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing. Past performance does not guarantee future results.
Frequently Asked Questions
- What is PLSE's 52-week high and low?
- In the last 52 weeks, Pulse Biosciences reached a high of $28.53 (on June 4, 2026) and a low of $12.56 (on November 20, 2025).
- What is the market cap and P/E ratio for PLSE?
- Curious about Pulse Biosciences's size and valuation? Its market capitalization stands at 1.65B. When it comes to valuation, the P/E ratio (trailing twelve months) is N/A, and the forward P/E (looking ahead) is -27.88.
- Does PLSE pay dividends? If so, what's the yield?
- As for dividends, Pulse Biosciences isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Pulse Biosciences's main competitors or similar companies to consider before investing?
When looking at Pulse Biosciences, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Intuitive Surgical
ISRG170.06B Healthcare Medical Instruments & Supplies -19.74% 24.81% Becton, Dickinson
BDX56.10B Healthcare Medical Instruments & Supplies 8.01% -28.08% AtriCure
ATRC1.43B Healthcare Medical Instruments & Supplies -8.95% -40.16% Staar Surgical
STAA1.23B Healthcare Medical Instruments & Supplies 66.10% -46.07% Anbio Biotechnology
NNNN1.20B Healthcare Medical Instruments & Supplies 80.02% 170.19% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Pulse Biosciences Inc.? (e.g., ROE, Debt/Equity)
- To get a sense of Pulse Biosciences's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is -74.45%, the Debt to Equity ratio from the most recent quarter is 9.34, and its Gross Profit Margin stands at 1.52%.
- What is the recent revenue and earnings growth for PLSE?
- Looking at Pulse Biosciences's growth, its revenue over the trailing twelve months (TTM) was $350K. Compared to the same quarter last year (YoY), quarterly revenue grew by 206.98%, and quarterly earnings saw a YoY growth of N/A.
- How much of PLSE stock is held by insiders and institutions?
- Wondering who owns Pulse Biosciences stock? Company insiders (like executives and directors) hold about 73.70% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 9.52%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.